Methyl 5-bromo-3-methyl-pyridine-2-carboxylate, 95.0%, 1g

2-(ethylthio)propanoic acid, 95.0%, 1g

[2-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)phenyl]-morpholin-4-yl-methanone, 98%, 1g

2-(Benzo[b]thiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

2,3-Difluoro-4-methylacetophenone, 5g

GC capillary column ROTI®Cap-1701, 50 m, 0.25 mm, 0.25 µm, 1 Piece(s)

4-Methoxy-3-nitrobenzotrifluoride, 98.0%, 10g

tert-Butyl 3-(2-aminoethyl)azetidine-1-carboxylate, 95.0%, 1g

4-Amino-2-fluoro-5-methoxybenzonitrile, 95.0%, 10g

(1R,1'R)-1,1'-((4R,5R)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)bis(ethane-1,2-diol), 95.0%, 5g

[(cyclopropylmethyl)sulfinyl]acetic acid, 95.0%, 1g

(4-Iodopyridin-2-yl)methanol, 95%, 100mg

4-Bromo-5-methyl-1H-pyrrolo[2,3-b]pyridine, 95.0%, 50mg